Efficacy and Safety of Mesalamine 1 g HS Versus 500 mg BID Suppositories in Mild to Moderate Ulcerative Proctitis: A Multicenter Randomized Study

Abstract

This study showed that 1 g HS and 500 mg BID mesalamine suppository treatments of UP patients were equivalent in all facets of efficacy, safety, and compliance in a 6-week trial.